Advances in multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer starvation therapy
- PMID: 39397711
- PMCID: PMC11488333
- DOI: 10.1017/erm.2024.28
Advances in multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer starvation therapy
Abstract
Cancer remains a significant threat to human health today. Even though starvation therapy and other treatment methods have recently advanced to a new level of rapid development in tumour treatment, their limited therapeutic effectiveness and unexpected side effects prevent them from becoming the first option in clinical treatment. With rapid advancement in nanotechnology, the utilization of nanomaterials in therapeutics offers the potential to address the shortcomings in cancer treatment. Notably, multifunctional metal-organic framework (MOF) has been widely employed in cancer therapy due to their customizable shape, adjustable diameter, high porosity, diverse compositions, large specific surface area, high degree of functionalization and strong biocompatibility. This paper reviews the current progress and success of MOF-based multifunctional nanoplatforms for cancer starvation therapy, as well as the prospects and potential barriers for the application of MOF nanoplatforms in cancer starvation therapy.
Keywords: biomaterials; cancer starvation therapy; metal-organic framework; nanomaterials; tumour.
Conflict of interest statement
All authors read and approved the final manuscript. They declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Multifunctional metal-organic framework (MOF)-based nanoplatforms for cancer therapy: from single to combination therapy.Theranostics. 2023 Jan 1;13(1):295-323. doi: 10.7150/thno.80687. eCollection 2023. Theranostics. 2023. PMID: 36593957 Free PMC article. Review.
-
Metal-organic frameworks as nanoplatforms for combination therapy in cancer treatment.Med Oncol. 2024 Dec 9;42(1):26. doi: 10.1007/s12032-024-02567-3. Med Oncol. 2024. PMID: 39653960 Review.
-
Recent advances in the development of metal-organic framework-based gas-releasing nanoplatforms for synergistic cancer therapy.Dalton Trans. 2021 Feb 2;50(4):1189-1196. doi: 10.1039/d0dt03767b. Dalton Trans. 2021. PMID: 33438684 Review.
-
Metal-Organic Framework-Based Nanomedicines for Ferroptotic Cancer Therapy.Adv Healthc Mater. 2024 Apr;13(11):e2303533. doi: 10.1002/adhm.202303533. Epub 2024 Jan 14. Adv Healthc Mater. 2024. PMID: 38221753 Review.
-
Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy.Dalton Trans. 2020 Aug 18;49(32):11045-11058. doi: 10.1039/d0dt01882a. Dalton Trans. 2020. PMID: 32756684 Review.
Cited by
-
Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments.Mater Today Bio. 2024 Dec 9;30:101386. doi: 10.1016/j.mtbio.2024.101386. eCollection 2025 Feb. Mater Today Bio. 2024. PMID: 39742149 Free PMC article. Review.
-
Supramolecular Nanozymes Based on Self-Assembly of Biomolecule for Cancer Therapy.Int J Nanomedicine. 2025 Feb 15;20:2043-2057. doi: 10.2147/IJN.S496831. eCollection 2025. Int J Nanomedicine. 2025. PMID: 39990286 Free PMC article. Review.
References
-
- Siegel RL et al. (2022) Cancer statistics, 2022. CA: A Cancer Journal for Clinicians 72, 7–33. - PubMed
-
- Wang C et al. (2019) Advanced nanotechnology leading the way to multimodal imaging-guided precision surgical therapy. Advanced Materials 31, e1904329. - PubMed
-
- Zhong Y et al. (2020) Recent advances in MOF-based nanoplatforms generating reactive species for chemodynamic therapy. Dalton Transactions 49, 11045–11058. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical